These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25682203)

  • 1. Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.
    Arama DP; Soualmia F; Lisowski V; Longevial JF; Bosc E; Maillard LT; Martinez J; Masurier N; El Amri C
    Eur J Med Chem; 2015 Mar; 93():202-13. PubMed ID: 25682203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors.
    Murafuji H; Sakai H; Goto M; Imajo S; Sugawara H; Muto T
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5272-5276. PubMed ID: 29102227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.
    Bellet V; Lichon L; Arama DP; Gallud A; Lisowski V; Maillard LT; Garcia M; Martinez J; Masurier N
    Eur J Med Chem; 2017 Jan; 125():1225-1234. PubMed ID: 27871038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors.
    Murafuji H; Sakai H; Goto M; Oyama Y; Imajo S; Sugawara H; Tomoo T; Muto T
    Bioorg Med Chem Lett; 2018 May; 28(8):1371-1375. PubMed ID: 29550094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
    Swedberg JE; Nigon LV; Reid JC; de Veer SJ; Walpole CM; Stephens CR; Walsh TP; Takayama TK; Hooper JD; Clements JA; Buckle AM; Harris JM
    Chem Biol; 2009 Jun; 16(6):633-43. PubMed ID: 19549601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones.
    Murafuji H; Sugawara H; Goto M; Oyama Y; Sakai H; Imajo S; Tomoo T; Muto T
    Bioorg Med Chem; 2018 Jul; 26(12):3639-3653. PubMed ID: 29884582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of plasma kallikrein.
    Young WB; Rai R; Shrader WD; Burgess-Henry J; Hu H; Elrod KC; Sprengeler PA; Katz BA; Sukbuntherng J; Mordenti J
    Bioorg Med Chem Lett; 2006 Apr; 16(7):2034-6. PubMed ID: 16413183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome.
    White GV; Edgar EV; Holmes DS; Lewell XQ; Liddle J; Polyakova O; Smith KJ; Thorpe JH; Walker AL; Wang Y; Young RJ; Hovnanian A
    Bioorg Med Chem Lett; 2019 Mar; 29(6):821-825. PubMed ID: 30691925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6).
    Fernández IS; Ständker L; Mägert HJ; Forssmann WG; Giménez-Gallego G; Romero A
    J Mol Biol; 2008 Apr; 377(5):1488-97. PubMed ID: 18329042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.
    Gallud A; Vaillant O; Maillard LT; Arama DP; Dubois J; Maynadier M; Lisowski V; Garcia M; Martinez J; Masurier N
    Eur J Med Chem; 2014 Mar; 75():382-90. PubMed ID: 24561668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreins.
    Tan X; Bertonati C; Qin L; Furio L; El Amri C; Hovnanian A; Reboud-Ravaux M; Villoutreix BO
    Eur J Med Chem; 2013; 70():661-8. PubMed ID: 24211642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors.
    Walker AL; Denis A; Bingham RP; Bouillot A; Edgar EV; Ferrie A; Holmes DS; Laroze A; Liddle J; Fouchet MH; Moquette A; Nassau P; Pearce AC; Polyakova O; Smith KJ; Thomas P; Thorpe JH; Trottet L; Wang Y; Hovnanian A
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126675. PubMed ID: 31521475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ahp-Cyclodepsipeptides as tunable inhibitors of human neutrophil elastase and kallikrein 7: Total synthesis of tutuilamide A, serine protease selectivity profile and comparison with lyngbyastatin 7.
    Chen QY; Luo D; Seabra GM; Luesch H
    Bioorg Med Chem; 2020 Dec; 28(23):115756. PubMed ID: 33002682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human kallikrein 6 inhibitors with a para-amidobenzylanmine P1 group identified through virtual screening.
    Liang G; Chen X; Aldous S; Pu SF; Mehdi S; Powers E; Xia T; Wang R
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2450-5. PubMed ID: 22386244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the first class of suicide inhibitors of kallikreins involved in skin diseases.
    Tan X; Soualmia F; Furio L; Renard JF; Kempen I; Qin L; Pagano M; Pirotte B; El Amri C; Hovnanian A; Reboud-Ravaux M
    J Med Chem; 2015 Jan; 58(2):598-612. PubMed ID: 25489658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of First-in-Class Inhibitors of Kallikrein-Related Peptidase 6 That Promote Oligodendrocyte Differentiation.
    Aït Amiri S; Deboux C; Soualmia F; Chaaya N; Louet M; Duplus E; Betuing S; Nait Oumesmar B; Masurier N; El Amri C
    J Med Chem; 2021 May; 64(9):5667-5688. PubMed ID: 33949859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
    Katz BA; Liu B; Barnes M; Springman EB
    Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isomannide derivatives as new class of inhibitors for human kallikrein 7.
    Freitas RF; Teixeira TS; Barros TG; Santos JA; Kondo MY; Juliano MA; Juliano L; Blaber M; Antunes OA; Abrahão O; Pinheiro S; Muri EM; Puzer L
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6072-5. PubMed ID: 22959247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
    Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
    Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.